Damien McDevitt Insider Trading $AKCA AKCEA THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Damien McDevitt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Damien McDevitt. Damien McDevitt is Chief Business Officer in IONIS PHARMACEUTICALS INC ($ISIS) and Chief Executive Officer in AKCEA THERAPEUTICS, INC. ($AKCA) and Interim Chief Executive Office in AKCEA THERAPEUTICS, INC. ($AKCA).
Damien McDevitt in AKCEA THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Damien McDevitt: Chief Executive Officer, Interim Chief Executive Office
Holdings: 0 shares
Latest Transaction: Oct 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Damien McDevitt in AKCEA THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 200,000 | 2,552,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 120,000 | 1,531,200 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Sell | U | 18.15 | 242,978 | 4,410,051 | 0 | 243 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 200,000 | 2,552,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | D | 12.76 | 120,000 | 1,531,200 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Sell | U | 18.15 | 242,978 | 4,410,051 | 0 | 243 K to 0 (-100.00 %) |
| Sep 24 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Sell | S | 18.12 | 8,709 | 157,807 | 242,978 | 251.7 K to 243 K (-3.46 %) |
| Sep 02 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Grant | A | 14.40 | 1,104 | 15,896 | 251,687 | 250.6 K to 251.7 K (+0.44 %) |
| Mar 25 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Sell | S | 11.75 | 9,417 | 110,649 | 245,783 | 255.2 K to 245.8 K (-3.69 %) |
| Mar 23 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | A | 12.76 | 200,000 | 2,552,000 | 200,000 | |
| Mar 23 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Option Exercise | A | 12.76 | 109,800 | 1,401,048 | 109,800 | |
| Mar 23 2020 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Chief Executive Off ... | Grant | A | 0.00 | 55,200 | 0 | 255,200 | 200 K to 255.2 K (+27.60 %) |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Interim Chief Execu ... | Option Exercise | A | 22.46 | 400,000 | 8,984,000 | 400,000 | |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | McDevitt Damien | Interim Chief Execu ... | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
Page: 1